India regulators to re-inspect 147 drug plants

Jan 14, 2018

A joint team of central and state drug regulators in India will re-inspect 147 drug manufacturing plants that have been under scrutiny over the last two years, reports the Economic Times.

The team will conduct a risk-based inspection exercise to ensure that drug manufacturing plants have taken measures to improve product quality. Companies that were found non-compliant during the first round of inspections — initiated in 2016 — were allowed time to plug deficiencies.

The re-inspections are expected to occur in the next three weeks and may involve punitive action against firms not complying with prescribed good manufacturing practices.

Read the Economic Times coverage 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments